Study reveals why H5N1 flu cases today are less severe than historic outbreaks

Study reveals that contemporary HPAI H5N1 viruses show reduced replication and immune activation in human lung organoids, potentially explaining milder disease in humans compared to historic strains.

Pharmalittle: We’re reading about Wegovy shipments, the NIH director’s plans, and more

Good morning, everyone, and welcome to another working week. We hope the weekend respite — which was extended on this side of the pond due

January 16, 2024

GLP-1 Drugs in MASLD Tied to Lower Risk of Cirrhosis, Death

GLP-1 receptor agonist use was associated with a reduced risk of progressing to cirrhosis and related complications in patients with diabetes and metabolic dysfunction-associated steatotic

September 17, 2024

Reviving reservoirs: new findings shake up HIV treatment understanding

Researchers provide insight into the interaction between T lymphocytes and persisting reservoirs of HIV, with repercussions for harnessing effective, long-lasting responses to HIV eradication.

September 14, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.